112 related articles for article (PubMed ID: 30608397)
1. Sentinel lymph node biopsy in patients affected by breast ductal carcinoma in situ with and without microinvasion: Retrospective observational study.
Bertozzi S; Cedolini C; Londero AP; Baita B; Giacomuzzi F; Capobianco D; Tortelli M; Uzzau A; Mariuzzi L; Risaliti A
Medicine (Baltimore); 2019 Jan; 98(1):e13831. PubMed ID: 30608397
[TBL] [Abstract][Full Text] [Related]
2. Is Sentinel Lymph Node Dissection Warranted for Patients with a Diagnosis of Ductal Carcinoma In Situ?
Francis AM; Haugen CE; Grimes LM; Crow JR; Yi M; Mittendorf EA; Bedrosian I; Caudle AS; Babiera GV; Krishnamurthy S; Kuerer HM; Hunt KK
Ann Surg Oncol; 2015 Dec; 22(13):4270-9. PubMed ID: 25905585
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of Omitting Sentinel Lymph Node Biopsy in an Under-screened Cohort of Breast Cancer Patients With a Premastectomy Diagnosis of Ductal Carcinoma In Situ.
Pang J; Yan Z; Tan QT; Allen JC; Wang M; Lim GH
Clin Breast Cancer; 2024 Jun; 24(4):363-367. PubMed ID: 38458843
[TBL] [Abstract][Full Text] [Related]
4. Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast.
Zavagno G; Carcoforo P; Marconato R; Franchini Z; Scalco G; Burelli P; Pietrarota P; Lise M; Mencarelli R; Capitanio G; Ballarin A; Pierobon ME; Marconato G; Nitti D
BMC Cancer; 2005 Mar; 5():28. PubMed ID: 15762990
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Imaging Characteristics of Contrast-enhanced Mammography and MRI to Distinguish Microinvasive Carcinoma from Ductal Carcinoma In situ.
Hua B; Yang G; An Y; Lou K; Chen J; Quan G; Yuan T
Acad Radiol; 2024 May; ():. PubMed ID: 38734581
[TBL] [Abstract][Full Text] [Related]
6. Could breast multiparametric MRI discriminate between pure ductal carcinoma in situ and microinvasive carcinoma?
Rizzo V; Cicciarelli F; Galati F; Moffa G; Maroncelli R; Pasculli M; Pediconi F
Acta Radiol; 2024 Jun; 65(6):565-574. PubMed ID: 38196268
[TBL] [Abstract][Full Text] [Related]
7. Selective omission of sentinel lymph node biopsy in mastectomy for ductal carcinoma in situ: identifying eligible candidates.
Bae SJ; Kook Y; Jang JS; Baek SH; Moon S; Kim JH; Lee SE; Kim MJ; Ahn SG; Jeong J
Breast Cancer Res; 2024 Apr; 26(1):65. PubMed ID: 38609935
[TBL] [Abstract][Full Text] [Related]
8. MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma
Guo Q; Li VZ; Nichol JN; Huang F; Yang W; Preston SEJ; Talat Z; Lefrère H; Yu H; Zhang G; Basik M; Gonçalves C; Zhan Y; Plourde D; Su J; Torres J; Marques M; Habyan SA; Bijian K; Amant F; Witcher M; Behbod F; McCaffrey L; Alaoui-Jamali M; Giannakopoulos NV; Brackstone M; Postovit LM; Del Rincón SV; Miller WH
Cancer Res; 2019 Apr; 79(7):1646-1657. PubMed ID: 30659022
[TBL] [Abstract][Full Text] [Related]
9. Impact of the presence and quantity of ductal carcinoma in situ component on the outcome of invasive breast cancer.
Cedolini C; Bertozzi S; Londero AP; Seriau L; Andretta M; Agakiza D; Fongione S; Uzzau A; Risaliti A
Int J Clin Exp Pathol; 2015; 8(10):13304-13. PubMed ID: 26722534
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for lymph node metastasis and the impact of adjuvant chemotherapy on ductal carcinoma in situ with microinvasion: a population-based study.
Chen C; Huang S; Huang A; Jia Y; Wang J; Zhang Z; Mao M; Wang L; Zhou J
Onco Targets Ther; 2018; 11():9071-9080. PubMed ID: 30588019
[TBL] [Abstract][Full Text] [Related]
11. New criteria to predict tumor recurrence in invasive ductal carcinoma of the breast.
Nozoe T; Mori E; Iguchi T; Ezaki T
Int Surg; 2013; 98(4):283-8. PubMed ID: 24229009
[TBL] [Abstract][Full Text] [Related]
12. Improving the diagnosis of ductal carcinoma in situ with microinvasion without immunohistochemistry: An innovative method with H&E-stained and multiphoton microscopy images.
Han X; Liu Y; Zhang S; Li L; Zheng L; Qiu L; Chen J; Zhan Z; Wang S; Ma J; Kang D; Chen J
Int J Cancer; 2024 May; 154(10):1802-1813. PubMed ID: 38268429
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the management of intracystic papillary carcinoma.
Beck M; Beltjens F; Arnould L; Coutant C; Vincent L
Bull Cancer; 2023; 110(7-8):810-817. PubMed ID: 37179238
[TBL] [Abstract][Full Text] [Related]
14. Microinvasive Carcinoma versus Ductal Carcinoma
Kim M; Kim HJ; Chung YR; Kang E; Kim EK; Kim SH; Kim YJ; Kim JH; Kim IA; Park SY
J Breast Cancer; 2018 Jun; 21(2):197-205. PubMed ID: 29963116
[TBL] [Abstract][Full Text] [Related]
15. Histological characteristics of tumors in blood vessels play an important role in tumor progression of invasive ductal carcinoma of the breast.
Hasebe T; Sasaki S; Imoto S; Ochiai A
Cancer Sci; 2003 Feb; 94(2):158-65. PubMed ID: 12708491
[TBL] [Abstract][Full Text] [Related]
16. Clinical Longevity of Preoperative Injection of Superparamagnetic Iron Oxide Nanoparticles for Delayed Sentinel Lymph Node Biopsy.
Muanamputu G; Sparkman BK; Louie RJ; McGuire KP
Am Surg; 2024 Apr; ():31348241244634. PubMed ID: 38576134
[TBL] [Abstract][Full Text] [Related]
17. Two Cases of Distant Metastasis After Mastectomy for Breast Ductal Carcinoma In Situ.
Hamaoka T; Bando H; Okazaki M; Iguchi-Manaka A; Hara H
Cureus; 2024 May; 16(5):e59655. PubMed ID: 38836147
[TBL] [Abstract][Full Text] [Related]
18. A case of ductal carcinoma in situ (DCIS) with markedly elevated CA15-3 levels requiring 2 years of diagnosis.
Fujimoto M; Kobayashi Y; Kuraoka K; Yoshiyama T; Shigematu H
Surg Case Rep; 2023 Dec; 9(1):209. PubMed ID: 38036933
[TBL] [Abstract][Full Text] [Related]
19. Rare Presentation of Papillary Carcinoma Within a Sentinel Lymph Node in a Patient With Ductal Carcinoma in Situ of the Breast: A Challenging but Useful Case Report Discussion Regarding Displacement or True Metastasis?
Sonam F; Komforti MK; Jakub JW; Cornell LF; Robinson KA
Int J Surg Pathol; 2024 Mar; ():10668969241235316. PubMed ID: 38500348
[TBL] [Abstract][Full Text] [Related]
20. Validation and Clinical Utility of a Prediction Model for the Risk of Upstaging to Invasive Breast Cancer After a Biopsy Diagnosis Ductal Carcinoma In Situ.
Meurs CJC; van Bekkum S; van Rosmalen J; Menke-Pluijmers MBE; Siesling S; Westenend PJ
Ann Surg Oncol; 2023 Nov; 30(12):7069-7080. PubMed ID: 37541961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
